Is Rewalk Robotics a good investment?
For investors eyeing innovative medical technology, ReWalk Robotics (LFWD) often sparks curiosity. The company, known for its wearable robotic exoskeletons that help individuals with spinal cord injuries walk again, operates in a niche yet rapidly evolving sector. While the technology is groundbreaking, the investment question is more nuanced.
Wall Street analysts are divided but generally optimistic over the short term. The average 1-year price target for LFWD stands at $20.40, suggesting upside potential from current levels. However, forecasts vary widely, with estimates ranging from a low of $10.10 to a high of
Comments
No comments yet. Be the first to react.